|
⚲
|
| Keyboard |
| Lawrence Kenyon | |
|---|---|
| Firm | |
| Address | c/o Outlook Therapeutics, Inc 111 South Wood Avenue, Unit 100 Iselin, NJ 08830 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Outlook Therapeutics Inc | 021-536382 | Executive Officer | of 32.0 M |
||
| Outlook Therapeutics Inc | 021-510786 | Executive Officer | 5.0 M of 13.3 M |
||
| Outlook Therapeutics Inc | 021-509111 | Executive Officer | 60.0 M of 159.0 M |
||
| Outlook Therapeutics Inc | 021-469961 | Executive Officer | 31.8 M of 31.8 M |
||
| Outlook Therapeutics Inc | 021-469963 | Executive Officer | 1.0 M of 1.0 M |
||
| Outlook Therapeutics Inc | 021-389278 | Executive Officer | 4.0 M of 4.0 M |
||
| Outlook Therapeutics Inc | 021-368584 | Executive Officer | 16.0 M of 16.0 M |
||
| Outlook Therapeutics Inc | 021-362487 | Executive Officer | 8.0 M of 8.0 M |
||
| Oncobiologics Inc | 021-295363 | Executive Officer | 3.3 M of 40.1 M |
||
| Oncobiologics Inc | 021-253745 | Executive Officer | 6.3 M of 50.0 M |
||
| Oncobiologics Inc | 021-249236 | Executive Officer | 14.5 M of 14.5 M |
||
| Tamir Biotechnology Inc | 021-189029 | Executive Officer | 1.0 M of 1.0 M |
||